Form 4 for QTEX QTREX Quantum Ltd.
Accepted 2026-09-01 16:06:17 ET · period of report 2026-08-28 · accession 0001185185-26-003786 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 16:06 | 2026-08-28 | QTEX | Ben-Noon Dagi Shahar | CEO, Dir | A - Grant | $0.00 | +550.0K | 2.48M | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-08-28 | A | A | 550,000 | $0.00 | 2,477,239 | D | — | — | (F1) The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: (i) 33.34% of the RSUs will vest on the first anniversary date following July 1, 2026 (the "First Instalment"); and (ii) 8.33% of the RSUs will vest on a quarterly basis over 8 quarters (two (2) years), following the First Instalment. The grant of RSUs was approved by the Company's shareholders at an Extraordinary General Meeting of Shareholders held on August 28, 2026. |